Target
Integrase
Ligand
BDBM505
Substrate
n/a
Meas. Tech.
ChEMBL_90721 (CHEMBL701114)
IC50
18000±n/a nM
Citation
 Mazumder, AWang, SNeamati, NNicklaus, MSunder, SChen, JMilne, GWRice, WGBurke, TRPommier, Y Antiretroviral agents as inhibitors of both human immunodeficiency virus type 1 integrase and protease. J Med Chem 39:2472-81 (1996) [PubMed]  Article 
Target
Name:
Integrase
Synonyms:
Human immunodeficiency virus type 1 integrase
Type:
PROTEIN
Mol. Mass.:
32231.48
Organism:
Human immunodeficiency virus 1
Description:
ChEMBL_90865
Residue:
288
Sequence:
FLDGIDKAQDEHEKYHSNWRAMASDFNLPPVVAKEIVASCDKCQLKGEAMHGQVDCSPGIWQLDCTHLEGKVILVAVHVASGYIEAEVIPAETGQETAYFLLKLAGRWPVKTIHTDNGSNFTSTTVKAACWWAGIKQEFGIPYNPQSQGVVESMNKELKKIIGQVRDQAEHLKTAVQMAVFIHNFKRKGGIGGYSAGERIVDIIATDIQTKELQKQITKIQNFRVYYRDSRDPLWKGPAKLLWKGEGAVVIQDNSDIKVVPRRKVKIIRDYGKQMAGDDCVASRQDED
  
Inhibitor
Name:
BDBM505
Synonyms:
3-[2H-1,3-benzodioxol-5-yl(4-hydroxy-2-oxo-2H-chromen-3-yl)methyl]-4-hydroxy-2H-chromen-2-one | CHEMBL64213 | Cancer Chemotherapy National Service Center (CCNSC) compound 373937 | NSC 373937
Type:
Small organic molecule
Emp. Form.:
C26H16O8
Mol. Mass.:
456.4004
SMILES:
Oc1c(C(c2ccc3OCOc3c2)c2c(O)c3ccccc3oc2=O)c(=O)oc2ccccc12
Structure:
Search PDB for entries with ligand similarity: